GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (OTCPK:DNPUF) » Definitions » Cyclically Adjusted PB Ratio

Sumitomo Pharma Co (Sumitomo Pharma Co) Cyclically Adjusted PB Ratio : 0.30 (As of Apr. 30, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sumitomo Pharma Co Cyclically Adjusted PB Ratio?

As of today (2024-04-30), Sumitomo Pharma Co's current share price is $2.70. Sumitomo Pharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $8.88. Sumitomo Pharma Co's Cyclically Adjusted PB Ratio for today is 0.30.

The historical rank and industry rank for Sumitomo Pharma Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

DNPUF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.26   Med: 1.46   Max: 3.7
Current: 0.31

During the past years, Sumitomo Pharma Co's highest Cyclically Adjusted PB Ratio was 3.70. The lowest was 0.26. And the median was 1.46.

DNPUF's Cyclically Adjusted PB Ratio is ranked better than
90.17% of 651 companies
in the Drug Manufacturers industry
Industry Median: 1.76 vs DNPUF: 0.31

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sumitomo Pharma Co's adjusted book value per share data for the three months ended in Dec. 2023 was $6.006. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $8.88 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sumitomo Pharma Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sumitomo Pharma Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Cyclically Adjusted PB Ratio Chart

Sumitomo Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.64 1.30 1.71 1.00 0.62

Sumitomo Pharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.62 0.49 0.41 0.35

Competitive Comparison of Sumitomo Pharma Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sumitomo Pharma Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sumitomo Pharma Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sumitomo Pharma Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sumitomo Pharma Co's Cyclically Adjusted PB Ratio falls into.



Sumitomo Pharma Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sumitomo Pharma Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.70/8.88
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sumitomo Pharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Sumitomo Pharma Co's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=6.006/106.8000*106.8000
=6.006

Current CPI (Dec. 2023) = 106.8000.

Sumitomo Pharma Co Quarterly Data

Book Value per Share CPI Adj_Book
201403 9.802 95.700 10.939
201406 9.769 98.000 10.646
201409 9.840 98.500 10.669
201412 9.540 97.900 10.407
201503 9.429 97.900 10.286
201506 9.322 98.400 10.118
201509 9.544 98.500 10.348
201512 9.685 98.100 10.544
201603 8.683 97.900 9.472
201606 10.174 98.100 11.076
201609 10.357 98.000 11.287
201612 10.279 98.400 11.156
201703 9.190 98.100 10.005
201706 10.716 98.500 11.619
201709 11.270 98.800 12.183
201712 11.513 99.400 12.370
201803 10.745 99.200 11.568
201806 10.698 99.200 11.518
201809 11.027 99.900 11.789
201812 11.172 99.700 11.968
201903 11.281 99.700 12.084
201906 11.399 99.800 12.199
201909 11.976 100.100 12.778
201912 11.995 100.500 12.747
202003 12.453 100.300 13.260
202006 12.659 99.900 13.533
202009 12.955 99.900 13.850
202012 13.269 99.300 14.271
202103 13.444 99.900 14.373
202106 13.122 99.500 14.085
202109 13.305 100.100 14.196
202112 13.284 100.100 14.173
202203 12.904 101.100 13.632
202206 12.645 101.800 13.266
202209 11.351 103.100 11.758
202212 11.850 104.100 12.157
202303 7.660 104.400 7.836
202306 7.425 105.200 7.538
202309 7.014 106.200 7.054
202312 6.006 106.800 6.006

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sumitomo Pharma Co  (OTCPK:DNPUF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sumitomo Pharma Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sumitomo Pharma Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sumitomo Pharma Co (Sumitomo Pharma Co) Business Description

Traded in Other Exchanges
Address
6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045
Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.